C avernous malformations (CMs) are angiographically occult, low-flow vascular lesions that are found in 0.4%-0.8% of the general population. 8, 22, 26 Familial CMs can be associated with mutations in the CCM and KRIT genes leading to vasculogenesis. 3, 16, 17 Bleeding rates for clinically unruptured CMs range from 1% to 2% per year, 12,14 although MRI always shows old blood deposition in the malformation. After an initial clinically recognized hemorrhage, the risk of additional hemorrhages increases to 4% per year and can be as high as 34% per year after 2 or more bleeds.
3 patients; 34 however, obliteration of the luminal area was less drastic in CMs than in arteriovenous malformations (AVMs). Gewirtz et al. found fibrosis of vascular channels, fibrinoid necrosis, and ferrugination in 8 patients with CMs treated with SRS. 10 Tissue samples in these studies were obtained from resections following SRS or conventional irradiation. The limitation in an analysis of resected samples is the potential bias in evaluating only the CMs that do not respond to SRS.
According to previous studies, after SRS, between 8% and 17% of patients require delayed resection because of continued hemorrhagic events. 11, 13, 19 To better understand the causes of repeated bleeding of CMs following SRS, we performed a histopathological analysis of the resected specimens in 4 patients who had undergone delayed microsurgery.
methods
The University of Pittsburgh institutional review board approved this retrospective analysis. During the interval between 2001 and 2013, 9 cases of CM had recurrent bleeding after Leksell Gamma Knife surgery (median 31 months, range 6-57 months). Patients in 5 of these cases underwent subsequent resection of their CMs. One tissue sample obtained during microsurgical resection was small and insufficient for analysis. Thus, CMs from the remaining 4 patients were used to perform detailed histopathological analyses. The intervals between SRS and microsurgery were 4 months, 2.5 years, 3 years, and 7 years (Table 1) .
histology and immunohistochemistry
Formalin-fixed paraffin-embedded 4-to 6-mm sections were stained with H & E. Gomori's Modified Iron Stain and Masson's trichrome stain were used to evaluate blood vessel walls and demonstrate hemosiderin. Immunohistochemistry for vascular endothelial growth factor (VEGF; mouse monoclonal antibody, 1:100, Millipore), basic fibroblast growth factor (bFGF; Biogenex ready-to-use kit), and matrix metallopeptidase 9 (MMP-9; 1:50, GeneTex) was performed on 4-to 6-mm tissue sections. Pretreatment of sections for VEGF and MMP-9 consisted of antigen retrieval citrate buffer (1×, pH 6, Biogenex) in a steam chamber for 20 minutes and cooling for 20 minutes. No pretreatment was used for the bFGF. Each primary antibody was incubated for 45 minutes at room temperature in a humid slide chamber. Goat anti-mouse secondary antibody (Dako) was used on VEGF and MMP-9 (1:200) for 30 minutes. The EnVision system anti-mouse antibody (Dako) was used for 30 minutes for bFGF. The Vectastain ABC kit (Vector Labs) was applied to VEGF and MMP-9 for an additional 30 minutes for biotinylated enzyme activity. Sections were subsequently developed using the Vectastain ABC kit with the NovaRED peroxidase substrate kit (Vector Labs) and counterstained with Mayer's hematoxylin and lithium carbonate solution.
illustrative cases
The 4 patients analyzed in this study had samples from resections performed at different periods following SRS. These samples were also obtained from 4 different anatomical locations: right thalamus/midbrain region, right pons, left mesial temporal lobe, and left pons.
case 1

History and Examination
A 23-year-old female presented with acute-onset facial and oral numbness accompanied by mild frontal headache. Computed tomography studies of her brain demonstrated a 2 × 2-cm acute right thalamic hemorrhage that extended into the midbrain. Magnetic resonance imaging findings were compatible with a hemorrhagic CM. Given the lesion location and after discussing different options, observation was elected. The patient presented 6 months later with diplopia and left paresis, associated with further hemorrhage on MRI. She was discharged after stabilization and returned 2 months later for SRS.
Operation and Postoperative Course
The patient underwent Gamma Knife surgery: a 28.2-Gy maximum dose and 14-Gy margin dose delivered to a 2.33-cm 3 malformation in a single session. Three months after SRS the patient reported worsening headaches, and repeat MRI demonstrated a new hemorrhage. She again improved over the course of 48 hours with no neurological deficits. One month later she experienced another acuteonset headache, which progressed to left paresis, with an increase in the hemorrhage to 2.6 cm 3 (Fig. 1A) . She underwent microsurgical removal of the CM via a right subtemporal craniotomy, and the CM was resected en bloc. Six months postoperatively, she had persistent but markedly improved left paresis.
Histology and Immunohistochemistry
H & E-stained sections showed vascular sclerosis ( Fig.  2A ) and mineralization of vessels (Fig. 2B ), but in some areas there were still numerous small vessels with thin fibrous walls according to trichrome stain (Fig. 2C ). These vessels often stained positive for VEGF (Fig. 2D ), whereas the sclerotic vessels did not. MMP-9 stained macrophages and showed diffuse staining in areas near these small vessels, but bFGF was negative. Hemosiderin from a previous hemorrhage was abundant, consistent with the patient's clinical history.
case 2
History and Examination
A 31-year-old male presented with 2 pontine hemorrhages during an 18-month period. The bleeds resulted in a progressive left paresis, right abducens paresis, and diffuse left sensory loss involving the face, arm, and leg. Magnetic resonance imaging demonstrated a hemorrhagic lesion in the right aspect of the pons (Fig. 1B) .
Operation and Postoperative Course
Stereotactic radiosurgery was performed: 30-Gy maximum dose and 15-Gy margin dose delivered to a 2.8-cm 3 volume. Two and one-half years after SRS, the patient had worsening diplopia and new right-sided facial nerve palsy. Magnetic resonance imaging showed recurrent and progressive hemorrhagic enlargement of the pontine CM. He underwent suboccipital craniectomy and had subtotal resection of the CM. Two months later, he continued to have persistent diplopia and facial weakness.
Histology and Immunohistochemistry
Examination of H & E and trichrome staining of the stereotactic biopsy specimen prior to SRS demonstrated ectatic back-to-back blood vessels characteristic of a CM (Fig. 3A) . Resected CM tissue 2.5 years after SRS revealed incomplete vascular sclerosis and luminal narrowing (Fig. 3B) . Vascular endothelial growth factor staining was weak, possibly because of cautery artifact. MMP-9 stained macrophages and showed diffuse staining in areas near these small vessels, but bFGF was negative.
case 3
History and Examination
A 16-year-old epileptic female underwent partial resection of a left mesial temporal CM (Fig. 1C) . Nine years later, when she was 25 years old, she presented with progressive right-sided weakness and uncontrolled partial seizures.
Operation and Postoperative Course
The residual CM was treated with Gamma Knife surgery: 30-Gy maximum dose and 15-Gy margin dose delivered to a 1-cm 3 volume. Three years later, the frequency of seizures again increased, and she underwent repeat resection via a pterional craniotomy. Postoperative confusion and right-sided weakness gradually resolved within 5 days. One year after surgery her seizures were reduced in frequency while on antiepileptic medication.
Histology and Immunohistochemistry
H & E and trichrome stains of the resected CM 3 years after SRS revealed many sclerosed vessels, which were sometimes accompanied by increased numbers of smaller vessels (Fig. 4A) . Immunostaining for VEGF was light in these vessels (Fig. 4B ), but the tissue showed severe cautery artifact as well. The presence of erythrocytes adjacent to the residual patent vessels suggested persistent microhemorrhage in the malformation despite the absence of MRI evidence of interval hemorrhage. There were also MMP-9-stained macrophages and diffuse staining of VEGF in areas near the vessels, but bFGF was negative.
Case 4
History and Examination
A 51-year-old female presented with a 1-week history of facial numbness, dizziness, and blurred vision. A CT scan demonstrated a left pontine hemorrhage from a CM. Repeat MRI indicated further hemorrhage.
Operation and Postoperative Course
The patient underwent clot evacuation via a suboccipital craniotomy. Since postoperative imaging demonstrated a residual CM she underwent Gamma Knife surgery 4 months later: 28-Gy maximum dose and 14-Gy margin dose delivered to a 0.65-cm 3 volume. She remained well until 7 years later, when she developed a new left-sided facial droop and right-sided facial numbness. Imaging studies demonstrated a new hemorrhage extending into the fourth ventricle (not shown in Fig. 1D ). She underwent suboccipital craniotomy and resection of the entire CM.
Histology and Immunohistochemistry
H & E-stained sections showed prominent vascular sclerosis with fibrinoid necrosis and hyalinization ( Fig. 5A  and C) . Trichrome stains showed that most vessels were completely sclerotic, but focally there were dilated thinwalled vessels with little sclerosis (Fig. 5B) as well as robust staining for VEGF (Fig. 5D ).
discussion rationale for srs in cms
Previous publications have indicated that the risk of additional bleeds from repeatedly hemorrhagic CMs declines following SRS from as high as 50% per year to 8%-10% in the first 2 years to 1%-1.4% thereafter. 1, 5, 13, 18, 19, 21, 24 Although Karlsson et al. 11 have remained skeptical about the eventual bleeding risk protection of SRS, they noted a trend for a decreasing hemorrhage rate 4 years after SRS. They also noted that higher radiosurgical doses reduce the risk of posttreatment hemorrhage. This slow reduction in hemorrhage risk years indicates that the time course of SRS obliteration took years to complete. During this latency interval, CM patients can have recurrent hemorrhages. Since most patients with CM who undergo SRS have deep-seated malformations that have repeatedly bled, it is not surprising that relatively few histological studies have been reported. To further understand the potential reasons for recurrent hemorrhages despite SRS, we studied the histological findings in 4 patients who required resection of a CM because of repeated bleeds.
histological response of vascular malformation blood vessels
Stereotactic radiosurgery for AVMs results in progressive luminal thrombosis in response to endothelial proliferation, creation of intraluminal myofibroblasts, and hyalinization and sclerosis of the treated blood vessel walls. Tu et al. found that there were proteinaceous thrombi and hyalinized vessel walls in both AVMs and CMs; 34 however, a notable difference was the near complete or complete occlusion of the AVMs but the partial occlusion of the CMs after SRS. Cavernous malformations after irradiation commonly had fibrinoid necrosis but patent vascular channels. We detected partially obliterated vessels and wall sclerosis as early as 4 months after SRS. However, as may be suspected this soon after SRS, most of the vessels were not sclerosed. Such patent vessels are prone to hemorrhage until further sclerosis and obliteration occurs. In agreement with this finding, there is a higher hemorrhage risk within the first 2 years following SRS, as demonstrated in our previous studies. 13, 19, 21 Obliterated vessels are found more commonly in histological samples from patients who have undergone surgery at 2.5 and 3 years after SRS. However, there are many larger vessels with sclerotic vascular walls but open lumen even at these time points. The lack of extensive vessel obliteration indicates that the patients are still at risk for hemorrhage from these large vessels. This finding is in agreement with our prior analysis demonstrating an annual rehemorrhage risk of 8.8% in the first 2 years and a decrease to 1.1% thereafter.
13
By 7 years after SRS in the present study, most vessels were completely obliterated. However, these histological samples also demonstrated smaller patent vessels. These vessels had a wide range of diameters, and most showed no signs of sclerosis. Stereotactic radiosurgery leads to hyalinization of CM vessel walls, 34 but these changes were not observed in small CM vessels with diameters on the order of capillaries and venules. Given that CMs proliferate via neoangiogenesis, 31 we hypothesize that small diameter neovasculature developed after the original radiation (SRS) exposure. This initial neovascularization may progress to become the more characteristic thin-walled large-lumen vessels seen in typical CMs. Despite the early effect of radiation in altering vessel morphology, neovascularization as well as continuing enlargement of thin-walled vessels should be considered as a possible mechanism underlying rehemorrhage even as late as 7 years after radiosurgery.
Prominent endothelial cells can be commonly found in either granulation tissue or larger vessels after SRS, similar to the organizing thrombi and neovascularization reported in nonirradiated CM. 28 The endothelial cells participating in neovascularization after irradiation have been previously studied in tumor xenograft models as well as ischemic injury models. Circulating endothelial progenitor cells from bone marrow have been shown to settle in areas of neovascularization and differentiate into endothelial cells. 2, 33 Although tumor and CM reactions to radiation may be different, these studies suggest that a possible source of endothelial cells are adjacent or circulating progenitor cells. With newly recruited endothelial cell progenitors, neovascularization may give rise to new vessels prone to hemorrhage.
A limitation of this study is the small number of samples. Among the 9 patients who had recurrent bleeding, only 5 cases were deemed appropriate for resection (1 case was excluded from the analysis because of inadequate tissue sample). The small number of cases may provide a selection bias since they are more serious bleeds resulting in medically intractable symptoms. In addition, the timeline for the evolution of CM is also inadequate since only samples from 4 months and 2.5, 3, and 7 years were found. Moreover, these samples are from different regions of the brain. However, a cautious conclusion of the effect of SRS was made through an analysis of various sections as well as immunostains for markers of neovascularization in this study.
conclusions
In this study, all 4 post-SRS CM cases had incomplete sclerosis of blood vessels, indicating a possible cause of rebleeding. In 3 cases there were vascular changes suspicious for neovascularization, suggesting that such changes could also play a role in some cases of rebleeding. It is possible that SRS results in vascular sclerosis, but stromal components continue to produce angiogenic factors that promote neovascularization. However, the number of cases in this study is too small to be definitive and warrants future study with a larger number of cases.
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